Content
05/19/2025
Sacramento, CA USA
Persist AI
completed $12 million Series A Round funding. Investors include
Spero Ventures (lead), MBX Capital, Eli Lilly and Company, SignalFire, Ford Street Ventures, Purdue Ventures, Good AI Capital, Cartography Capital, Asymmetry Ventures, 2048 Ventures, Innosphere Ventures, Y Combinator.
About
Persist AI is revolutionizing pharmaceutical development through AI-driven robotics for formulation development and CMC. By combining predictive AI models with automated robotic systems, Persist AI enables pharmaceutical companies to develop drug formulations in a fraction of the time and cost of traditional approaches. The company works across multiple modalities and formulation types to accelerate bringing novel therapeutics to patients. Persist AI is a Y Combinator-backed company, having graduated from the prestigious startup accelerator in 2023.
Startup
Sector:
AI
Biotech
Life Science
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
